Ramy Farid Sells 3,661 Shares of Schrodinger (NASDAQ:SDGR) Stock

Key Points

• CEO sale: Schrodinger CEO Ramy Farid sold 3,661 shares on March 5 at an average price of $12.91 (≈$47.3K), reducing his stake by about 1.09% to 330,824 shares valued at roughly $4.27M.
• Cluster of insider sales: Several other executives—including the CFO (1,631 shares) and multiple EVPs—sold shares in the Mar 4–6 window, a pattern that can increase near‑term selling pressure though it may reflect vesting/diversification.
• Mixed fundamentals: The company beat quarterly EPS and revenue estimates ($0.44 EPS vs −$0.13 expected; $87.24M revenue) but remains unprofitable with negative margins and ROE; SDGR trades near $12.74 (market cap ≈ $939M) and carries an average analyst rating of "Hold" with a $21.75 target.

Schrodinger, Inc. (NASDAQ:SDGR - Get Free Report) CEO Ramy Farid sold 3,661 shares of the business's stock in a transaction on Thursday, March 5th. The stock was sold at an average price of $12.91, for a total value of $47,263.51. Following the sale, the chief executive officer owned 330,824 shares in the company, valued at approximately $4,270,937.84. The trade was a 1.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Schrodinger Stock Performance

SDGR stock traded down $0.29 on Friday, reaching $12.74. The company had a trading volume of 976,433 shares, compared to its average volume of 1,475,655. The company's fifty day moving average is $14.88 and its 200 day moving average is $17.65. The company has a market cap of $938.56 million, a P/E ratio of -8.97 and a beta of 1.57. Schrodinger, Inc. has a 1 year low of $11.11 and a 1 year high of $27.63.

Schrodinger (NASDAQ:SDGR - Get Free Report) last announced its earnings results on Wednesday, February 25th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.13) by $0.57. Schrodinger had a negative net margin of 40.37% and a negative return on equity of 29.47%. The firm had revenue of $87.24 million for the quarter, compared to analyst estimates of $83.66 million. During the same quarter last year, the business earned ($0.24) earnings per share. Schrodinger's revenue was up 4.7% compared to the same quarter last year. On average, sell-side analysts predict that Schrodinger, Inc. will post -2.37 earnings per share for the current year.

Key Headlines Impacting Schrodinger

Here are the key news stories impacting Schrodinger this week:

• Positive Sentiment: Yahoo Finance piece highlights an evolving investment thesis as Schrödinger shifts toward hosted software and resets targets, which could support longer-term sentiment if adoption and ARR trajectory improve. How The Schrödinger (SDGR) Investment Story Is Evolving With Hosted Software And Reset Targets
• Neutral Sentiment: Transcript from Schrödinger’s TD Cowen conference presentation provides management commentary and detail that investors can use to re-assess guidance, product roadmap and commercialization progress; useful but not an immediate catalyst. Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
• Negative Sentiment: CEO Ramy Farid sold 3,661 shares at an average $12.91 (≈1.09% reduction in his stake), a high-profile insider sale that can signal near-term selling pressure. CEO Form 4
• Negative Sentiment: CFO Rachit Jain sold 1,631 shares at ~$12.90 (≈3.01% reduction), adding to the cluster of exec sales that market participants often interpret as a negative signal. CFO Form 4
• Negative Sentiment: Other senior leaders (EVPs Kenneth Lorton and Yvonne Tran, CAO Jenny Herman, and insiders Robert Abel, Karen Akinsanya) executed small-to-moderate sales (roughly 600–1,366 shares each around $12.80–$12.91), collectively reducing insider holdings and contributing to downward pressure. Sample Insider Filing (Robert Abel)
• Negative Sentiment: Multiple filings show these sales occurred within a short window (Mar 4–6), which magnifies market reaction compared with isolated, scheduled sales; however, each sale is a small percentage of total insider stakes and could reflect diversification or option/vesting activity rather than a change in corporate outlook. SEC Filings

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in Schrodinger by 2.0% during the 4th quarter. Vanguard Group Inc. now owns 6,464,426 shares of the company's stock valued at $115,584,000 after buying an additional 125,349 shares during the period. Rubric Capital Management LP lifted its position in Schrodinger by 5.4% in the third quarter. Rubric Capital Management LP now owns 5,268,817 shares of the company's stock worth $105,692,000 after purchasing an additional 268,817 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its stake in Schrodinger by 3.5% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,714,767 shares of the company's stock valued at $84,300,000 after purchasing an additional 160,198 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Schrodinger by 12.5% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,717,890 shares of the company's stock valued at $66,476,000 after buying an additional 414,231 shares during the period. Finally, Amova Asset Management Americas Inc. boosted its stake in Schrodinger by 6.8% during the fourth quarter. Amova Asset Management Americas Inc. now owns 2,819,670 shares of the company's stock valued at $50,359,000 after buying an additional 180,735 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the stock. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Schrodinger in a research report on Friday, January 9th. Wall Street Zen raised Schrodinger from a "sell" rating to a "hold" rating in a report on Saturday, January 31st. UBS Group started coverage on Schrodinger in a research report on Wednesday, January 7th. They issued a "neutral" rating and a $18.00 target price for the company. TD Cowen reissued a "buy" rating on shares of Schrodinger in a research report on Thursday, January 8th. Finally, KeyCorp decreased their price objective on shares of Schrodinger from $28.00 to $25.00 and set an "overweight" rating for the company in a report on Thursday, January 8th. Four equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Schrodinger currently has an average rating of "Hold" and an average target price of $21.75.

About Schrodinger

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.